{"transactions":[{"id":797047,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50600,"kind":"organization","name":"Bain Capital Life Sciences III General Partner, LLC","position":2,"cik":"0001952106","reported_name":"Bain Capital Life Sciences III General Partner, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50601,"kind":"organization","name":"Bain Capital Life Sciences Fund III, L.P.","position":3,"cik":"0001875273","reported_name":"Bain Capital Life Sciences Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50602,"kind":"organization","name":"BCLS Fund III Investments GP, LLC","position":4,"cik":"0001952080","reported_name":"BCLS Fund III Investments GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50603,"kind":"organization","name":"BCLS Fund III Investments, LP","position":5,"cik":"0001952107","reported_name":"BCLS Fund III Investments, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T00:46:31.000Z","date":"2026-04-30","kind":"sale","planned":false,"acquired":false,"shares":56224,"price":30.05,"value":1689531.2,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.19, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents securities held directly by BCLS Fund III Investments, LP (\"BCLS Fund III Investments\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Bain Capital Life Sciences Investors, LLC (\"BCLSI\") is the manager of Bain Capital Life Sciences III General Partner, LLC (\"BCLS Fund III GP\"), which is the general partner of Bain Capital Life Sciences Fund III, L.P. (\"BCLS Fund III\"), which is the managing member of BCLS Fund III Investments GP, LLC (\"BCLS Fund III Investments GP\"), which is the general partner of BCLS Fund III Investments. As a result, each of BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Investments. BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP each disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":8448158,"source":{"system":"sec-edgar","filing":"0001193125-26-198593","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1875273/000119312526198593/ownership.xml","form_type":"4"}},{"id":797046,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50600,"kind":"organization","name":"Bain Capital Life Sciences III General Partner, LLC","position":2,"cik":"0001952106","reported_name":"Bain Capital Life Sciences III General Partner, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50601,"kind":"organization","name":"Bain Capital Life Sciences Fund III, L.P.","position":3,"cik":"0001875273","reported_name":"Bain Capital Life Sciences Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50602,"kind":"organization","name":"BCLS Fund III Investments GP, LLC","position":4,"cik":"0001952080","reported_name":"BCLS Fund III Investments GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50603,"kind":"organization","name":"BCLS Fund III Investments, LP","position":5,"cik":"0001952107","reported_name":"BCLS Fund III Investments, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T00:46:31.000Z","date":"2026-04-30","kind":"sale","planned":false,"acquired":false,"shares":892533,"price":29.18,"value":26044112.94,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.995, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents securities held directly by BCLS Fund III Investments, LP (\"BCLS Fund III Investments\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Bain Capital Life Sciences Investors, LLC (\"BCLSI\") is the manager of Bain Capital Life Sciences III General Partner, LLC (\"BCLS Fund III GP\"), which is the general partner of Bain Capital Life Sciences Fund III, L.P. (\"BCLS Fund III\"), which is the managing member of BCLS Fund III Investments GP, LLC (\"BCLS Fund III Investments GP\"), which is the general partner of BCLS Fund III Investments. As a result, each of BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Investments. BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP each disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":8504382,"source":{"system":"sec-edgar","filing":"0001193125-26-198593","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875273/000119312526198593/ownership.xml","form_type":"4"}},{"id":797045,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50600,"kind":"organization","name":"Bain Capital Life Sciences III General Partner, LLC","position":2,"cik":"0001952106","reported_name":"Bain Capital Life Sciences III General Partner, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50601,"kind":"organization","name":"Bain Capital Life Sciences Fund III, L.P.","position":3,"cik":"0001875273","reported_name":"Bain Capital Life Sciences Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50602,"kind":"organization","name":"BCLS Fund III Investments GP, LLC","position":4,"cik":"0001952080","reported_name":"BCLS Fund III Investments GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50603,"kind":"organization","name":"BCLS Fund III Investments, LP","position":5,"cik":"0001952107","reported_name":"BCLS Fund III Investments, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T00:46:31.000Z","date":"2026-04-29","kind":"sale","planned":false,"acquired":false,"shares":797133,"price":29.37,"value":23411796.21,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.69, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents securities held directly by BCLS Fund III Investments, LP (\"BCLS Fund III Investments\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Bain Capital Life Sciences Investors, LLC (\"BCLSI\") is the manager of Bain Capital Life Sciences III General Partner, LLC (\"BCLS Fund III GP\"), which is the general partner of Bain Capital Life Sciences Fund III, L.P. (\"BCLS Fund III\"), which is the managing member of BCLS Fund III Investments GP, LLC (\"BCLS Fund III Investments GP\"), which is the general partner of BCLS Fund III Investments. As a result, each of BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Investments. BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP each disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":9396915,"source":{"system":"sec-edgar","filing":"0001193125-26-198593","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875273/000119312526198593/ownership.xml","form_type":"4"}},{"id":797044,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50600,"kind":"organization","name":"Bain Capital Life Sciences III General Partner, LLC","position":2,"cik":"0001952106","reported_name":"Bain Capital Life Sciences III General Partner, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50601,"kind":"organization","name":"Bain Capital Life Sciences Fund III, L.P.","position":3,"cik":"0001875273","reported_name":"Bain Capital Life Sciences Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50602,"kind":"organization","name":"BCLS Fund III Investments GP, LLC","position":4,"cik":"0001952080","reported_name":"BCLS Fund III Investments GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50603,"kind":"organization","name":"BCLS Fund III Investments, LP","position":5,"cik":"0001952107","reported_name":"BCLS Fund III Investments, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T00:46:31.000Z","date":"2026-04-28","kind":"sale","planned":false,"acquired":false,"shares":254110,"price":30.51,"value":7752896.1,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.50 to $31.46, inclusive. The reporting person undertakes to provide to Heartflow, Inc., any security holder of Heartflow, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents securities held directly by BCLS Fund III Investments, LP (\"BCLS Fund III Investments\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Bain Capital Life Sciences Investors, LLC (\"BCLSI\") is the manager of Bain Capital Life Sciences III General Partner, LLC (\"BCLS Fund III GP\"), which is the general partner of Bain Capital Life Sciences Fund III, L.P. (\"BCLS Fund III\"), which is the managing member of BCLS Fund III Investments GP, LLC (\"BCLS Fund III Investments GP\"), which is the general partner of BCLS Fund III Investments. As a result, each of BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Investments. BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP each disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":10194048,"source":{"system":"sec-edgar","filing":"0001193125-26-198593","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875273/000119312526198593/ownership.xml","form_type":"4"}},{"id":916141,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50600,"kind":"organization","name":"Bain Capital Life Sciences III General Partner, LLC","position":2,"cik":"0001952106","reported_name":"Bain Capital Life Sciences III General Partner, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50601,"kind":"organization","name":"Bain Capital Life Sciences Fund III, L.P.","position":3,"cik":"0001875273","reported_name":"Bain Capital Life Sciences Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50602,"kind":"organization","name":"BCLS Fund III Investments GP, LLC","position":4,"cik":"0001952080","reported_name":"BCLS Fund III Investments GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50603,"kind":"organization","name":"BCLS Fund III Investments, LP","position":5,"cik":"0001952107","reported_name":"BCLS Fund III Investments, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T21:58:06.000Z","date":"2026-02-04","kind":"sale","planned":false,"acquired":false,"shares":2000000,"price":28.05,"value":56100000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held directly by BCLS Fund III Investments, LP (\"BCLS Fund III Investments\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bain Capital Life Sciences Investors, LLC (\"BCLSI\") is the manager of Bain Capital Life Sciences III General Partner, LLC (\"BCLS Fund III GP\"), which is the general partner of Bain Capital Life Sciences Fund III, L.P. (\"BCLS Fund III\"), which is the managing member of BCLS Fund III Investments GP, LLC (\"BCLS Fund III Investments GP\"), which is the general partner of BCLS Fund III Investments. As a result, each of BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Investments. BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP each disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":10448158,"source":{"system":"sec-edgar","filing":"0001193125-26-041349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875273/000119312526041349/ownership.xml","form_type":"4"}},{"id":1067933,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50600,"kind":"organization","name":"Bain Capital Life Sciences III General Partner, LLC","position":2,"cik":"0001952106","reported_name":"Bain Capital Life Sciences III General Partner, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50601,"kind":"organization","name":"Bain Capital Life Sciences Fund III, L.P.","position":3,"cik":"0001875273","reported_name":"Bain Capital Life Sciences Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50602,"kind":"organization","name":"BCLS Fund III Investments GP, LLC","position":4,"cik":"0001952080","reported_name":"BCLS Fund III Investments GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50603,"kind":"organization","name":"BCLS Fund III Investments, LP","position":5,"cik":"0001952107","reported_name":"BCLS Fund III Investments, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Subordinated Convertible Promissory Note","published_at":"2025-08-13T20:00:11.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"price":0,"reported_value":6595648.51,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The outstanding principal amount of the Subordinated Convertible Promissory note automatically converted into shares of the Issuer's Common Stock upon consummation of the Issuer's initial public offering at a conversion price of 80% of the price per share in the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by BCLS Fund III Investments, LP (\"BCLS Fund III Investments\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Bain Capital Life Sciences Investors, LLC (\"BCLSI\") is the manager of Bain Capital Life Sciences III General Partner, LLC (\"BCLS Fund III GP\"), which is the general partner of Bain Capital Life Sciences Fund III, L.P. (\"BCLS Fund III\"), which is the managing member of BCLS Fund III Investments GP, LLC (\"BCLS Fund III Investments GP\"), which is the general partner of BCLS Fund III Investments. As a result, each of BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Investments. BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP each disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":15.2,"expiration_date":"2029-01-24","underlying":"Common Stock","underlying_shares":433924},"source":{"system":"sec-edgar","filing":"0000950170-25-107981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1875273/000095017025107981/ownership.xml","form_type":"4"}},{"id":1067932,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50600,"kind":"organization","name":"Bain Capital Life Sciences III General Partner, LLC","position":2,"cik":"0001952106","reported_name":"Bain Capital Life Sciences III General Partner, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50601,"kind":"organization","name":"Bain Capital Life Sciences Fund III, L.P.","position":3,"cik":"0001875273","reported_name":"Bain Capital Life Sciences Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50602,"kind":"organization","name":"BCLS Fund III Investments GP, LLC","position":4,"cik":"0001952080","reported_name":"BCLS Fund III Investments GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50603,"kind":"organization","name":"BCLS Fund III Investments, LP","position":5,"cik":"0001952107","reported_name":"BCLS Fund III Investments, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Stock","published_at":"2025-08-13T20:00:11.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":35081564,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 0.342466:1 basis immediately prior to the closing of the Issuer's initial public offering. These securities had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 0.342466:1 basis immediately prior to the closing of the Issuer's initial public offering. These securities had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 0.342466:1 basis immediately prior to the closing of the Issuer's initial public offering. These securities had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by BCLS Fund III Investments, LP (\"BCLS Fund III Investments\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Bain Capital Life Sciences Investors, LLC (\"BCLSI\") is the manager of Bain Capital Life Sciences III General Partner, LLC (\"BCLS Fund III GP\"), which is the general partner of Bain Capital Life Sciences Fund III, L.P. (\"BCLS Fund III\"), which is the managing member of BCLS Fund III Investments GP, LLC (\"BCLS Fund III Investments GP\"), which is the general partner of BCLS Fund III Investments. As a result, each of BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Investments. BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP each disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12014234},"source":{"system":"sec-edgar","filing":"0000950170-25-107981","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875273/000095017025107981/ownership.xml","form_type":"4"}},{"id":1067931,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50600,"kind":"organization","name":"Bain Capital Life Sciences III General Partner, LLC","position":2,"cik":"0001952106","reported_name":"Bain Capital Life Sciences III General Partner, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50601,"kind":"organization","name":"Bain Capital Life Sciences Fund III, L.P.","position":3,"cik":"0001875273","reported_name":"Bain Capital Life Sciences Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50602,"kind":"organization","name":"BCLS Fund III Investments GP, LLC","position":4,"cik":"0001952080","reported_name":"BCLS Fund III Investments GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50603,"kind":"organization","name":"BCLS Fund III Investments, LP","position":5,"cik":"0001952107","reported_name":"BCLS Fund III Investments, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T20:00:11.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":true,"shares":433924,"price":15.2,"value":6595644.8,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by BCLS Fund III Investments, LP (\"BCLS Fund III Investments\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Bain Capital Life Sciences Investors, LLC (\"BCLSI\") is the manager of Bain Capital Life Sciences III General Partner, LLC (\"BCLS Fund III GP\"), which is the general partner of Bain Capital Life Sciences Fund III, L.P. (\"BCLS Fund III\"), which is the managing member of BCLS Fund III Investments GP, LLC (\"BCLS Fund III Investments GP\"), which is the general partner of BCLS Fund III Investments. As a result, each of BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Investments. BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP each disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":12448158,"source":{"system":"sec-edgar","filing":"0000950170-25-107981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875273/000095017025107981/ownership.xml","form_type":"4"}},{"id":1067930,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50600,"kind":"organization","name":"Bain Capital Life Sciences III General Partner, LLC","position":2,"cik":"0001952106","reported_name":"Bain Capital Life Sciences III General Partner, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50601,"kind":"organization","name":"Bain Capital Life Sciences Fund III, L.P.","position":3,"cik":"0001875273","reported_name":"Bain Capital Life Sciences Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50602,"kind":"organization","name":"BCLS Fund III Investments GP, LLC","position":4,"cik":"0001952080","reported_name":"BCLS Fund III Investments GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50603,"kind":"organization","name":"BCLS Fund III Investments, LP","position":5,"cik":"0001952107","reported_name":"BCLS Fund III Investments, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T20:00:11.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":true,"shares":12014234,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 0.342466:1 basis immediately prior to the closing of the Issuer's initial public offering. These securities had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by BCLS Fund III Investments, LP (\"BCLS Fund III Investments\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Bain Capital Life Sciences Investors, LLC (\"BCLSI\") is the manager of Bain Capital Life Sciences III General Partner, LLC (\"BCLS Fund III GP\"), which is the general partner of Bain Capital Life Sciences Fund III, L.P. (\"BCLS Fund III\"), which is the managing member of BCLS Fund III Investments GP, LLC (\"BCLS Fund III Investments GP\"), which is the general partner of BCLS Fund III Investments. As a result, each of BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Investments. BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP each disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":12014234,"source":{"system":"sec-edgar","filing":"0000950170-25-107981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875273/000095017025107981/ownership.xml","form_type":"4"}},{"id":1329907,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50603,"kind":"organization","name":"BCLS Fund III Investments, LP","position":2,"cik":"0001952107","reported_name":"BCLS Fund III Investments, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50600,"kind":"organization","name":"Bain Capital Life Sciences III General Partner, LLC","position":3,"cik":"0001952106","reported_name":"Bain Capital Life Sciences III General Partner, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50601,"kind":"organization","name":"Bain Capital Life Sciences Fund III, L.P.","position":4,"cik":"0001875273","reported_name":"Bain Capital Life Sciences Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50602,"kind":"organization","name":"BCLS Fund III Investments GP, LLC","position":5,"cik":"0001952080","reported_name":"BCLS Fund III Investments GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82946,"kind":"organization","name":"BCLS II Investco, LP","position":6,"cik":"0001818893","reported_name":"BCLS II Investco, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82947,"kind":"organization","name":"BCLS II Investco (GP), LLC","position":7,"cik":"0001819101","reported_name":"BCLS II Investco (GP), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82944,"kind":"organization","name":"Bain Capital Life Sciences Fund II, L.P.","position":8,"cik":"0001773187","reported_name":"Bain Capital Life Sciences Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82945,"kind":"organization","name":"Bain Capital Life Sciences Investors II, LLC","position":9,"cik":"0001796155","reported_name":"Bain Capital Life Sciences Investors II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44736,"kind":"organization","name":"BCIP Life Sciences Associates, LP","position":10,"cik":"0001702921","reported_name":"BCIP Life Sciences Associates, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant (right to buy)","published_at":"2024-12-17T22:05:48.000Z","date":"2024-12-13","kind":"purchase","planned":false,"acquired":true,"shares":1632653,"price":24.4999,"value":39999835.2347,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The pre-funded warrants cannot be exercised if, as a result of such exercise, the holder, together with its affiliates and any other persons whose beneficial ownership would be aggregated with the holder for purposes of Section 13(d) of the Act, would beneficially own more than 9.99% of the total number of Ordinary Shares then outstanding immediately following such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The pre-funded warrants do not expire."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The pre-funded warrants cannot be exercised if, as a result of such exercise, the holder, together with its affiliates and any other persons whose beneficial ownership would be aggregated with the holder for purposes of Section 13(d) of the Act, would beneficially own more than 9.99% of the total number of Ordinary Shares then outstanding immediately following such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a pre-funded warrant to purchase 1,257,141 Ordinary Shares and a pre-funded warrant to purchase 375,512 Ordinary Shares, purchased by Bain Capital Life Sciences Opportunities III, LP (\"BCLS Fund III Opportunities\") and BCLS II Equity Opportunities, LP (\"BCLS Fund II Opportunities\"), respectively, in an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Bain Capital Life Sciences III General Partner, LLC (\"BCLS III GP\") is the general partner of Bain Capital Life Sciences Fund III, L.P. (\"BCLS III\"), which is the sole member of Bain Capital Life Sciences Opportunities III GP, LLC (\"BCLS Fund III Opportunities GP\"), which is the general partner of BCLS Fund III Opportunities. As a result, each of BCLS III GP and BCLS III may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Opportunities. Each of BCLS III GP and BCLS III disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Bain Capital Life Sciences Investors II, LLC (\"BCLSI II\") is the general partner of Bain Capital Life Sciences Fund II, L.P. (\"BCLS Fund II\"), which is the manager of BCLS II Equity Opportunities GP, LLC, which is the general partner of BCLS Fund II Opportunities. As a result, each of BCLSI II and BCLS Fund II may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund II Opportunities. Each of BCLSI II and BCLS Fund II disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Bain Capital Life Sciences Investors, LLC (\"BCLSI\") is the manager of each of BCLS III GP and BCLSI II. As a result, BCLSI may be deemed to share voting and dispositive power with respect to the securities held by each of BCLS Fund III Opportunities and BCLS Fund II Opportunities. BCLSI disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."}],"balance_after":1632653,"derivative":{"exercise_price":0.0001,"exercise_date":"2024-12-13","underlying":"Ordinary Shares","underlying_shares":1632653},"source":{"system":"sec-edgar","filing":"0000950170-24-137335","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818893/000095017024137335/ownership.xml","form_type":"4"}}]}